Tapewire

NYSE · USD

AMN

AMN HEALTHCARE SERVICES INC

Export transactions ↓
Tapewire entity
4780
SEC CIK
0001142750
Parsed reports
393

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 28, 2025 Filed Dec 2, 2025 15:22 UTC
Grace CarolineDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,552 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-054616 · wk-form4_1764688948.xml · nonDerivative · entry 3

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,997

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares acquired on the vesting of Restricted Stock Units.

Read SEC document
November 28, 2025 Filed Dec 2, 2025 15:22 UTC
Grace CarolineDirector · Chief Executive Officer
Tax withholdingCommon Stock 676 $17.22 $11,640.72
Disclosure

SEC source: 0001628280-25-054616 · wk-form4_1764688948.xml · nonDerivative · entry 2

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,445

F2 · kind: Shares withheld for tax purposes.

Read SEC document
November 28, 2025 Filed Dec 2, 2025 15:22 UTC
Grace CarolineDirector · Chief Executive Officer
Exercise / conversionCommon Stock 2,776 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-054616 · wk-form4_1764688948.xml · nonDerivative · entry 1

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,121

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares acquired on the vesting of Restricted Stock Units.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 15:24 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 4,976 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-045309 · wk-form4_1760714653.xml · derivative · entry 3

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,976

Underlying: Common Stock · 4,976 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on October 15, 2024 and vest in two tranches on the first and second anniversaries of the grant date and the grantee's provision of two periods of credited service

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 15:24 UTC
Laughlin Whitney MChief Legal Officer
Tax withholdingCommon Stock 1,212 $20.69 $25,076.28
Disclosure

SEC source: 0001628280-25-045309 · wk-form4_1760714653.xml · nonDerivative · entry 2

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,496

F2 · kind: Number of shares withheld for tax purposes.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 15:24 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionCommon Stock 4,976 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-045309 · wk-form4_1760714653.xml · nonDerivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,708

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common stock acquired on the vesting of Restricted Stock Units.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 15:54 UTC
Hagan Mark ChristopherChief Information and Digital
Exercise / conversionRestricted Stock Units · Derivative 9,330 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-045313 · wk-form4_1760716493.xml · derivative · entry 3

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,331

Underlying: Common Stock · 9,330 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on October 15, 2024 and vest in two tranches on the first and second anniversaries of the grant date and the grantee's provision of two periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 15:54 UTC
Hagan Mark ChristopherChief Information and Digital
Tax withholdingCommon Stock 3,339 $20.69 $69,083.91
Disclosure

SEC source: 0001628280-25-045313 · wk-form4_1760716493.xml · nonDerivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,699

F2 · kind: Number of shares withheld for tax purposes.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 15:54 UTC
Hagan Mark ChristopherChief Information and Digital
Exercise / conversionCommon Stock 9,330 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-045313 · wk-form4_1760716493.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,038

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common stock acquired on the vesting of Restricted Stock Units.

Read SEC document
September 15, 2025 Filed Sep 16, 2025 14:12 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 483 $0.00 $0.00
Disclosure

SEC source: 0001992434-25-000004 · wk-form4_1758031948.xml · derivative · entry 3

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 498

Underlying: Common Stock · 483 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on September 15, 2023 and vest in three tranches on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
September 15, 2025 Filed Sep 16, 2025 14:12 UTC
Laughlin Whitney MChief Legal Officer
Tax withholdingCommon Stock 118 $18.25 $2,153.50
Disclosure

SEC source: 0001992434-25-000004 · wk-form4_1758031948.xml · nonDerivative · entry 2

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,732

F2 · kind: Number of shares withheld for tax purposes.

Read SEC document
September 15, 2025 Filed Sep 16, 2025 14:12 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionCommon Stock 483 $0.00 $0.00
Disclosure

SEC source: 0001992434-25-000004 · wk-form4_1758031948.xml · nonDerivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,850

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common stock acquired on the vesting of Restricted Stock Units.

Read SEC document
June 15, 2025 Filed Jun 16, 2025 20:30 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 496 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000037 · wk-form4_1750105818.xml · derivative · entry 3

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 496 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on June 15, 2022 and vest on the third anniversary of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
June 15, 2025 Filed Jun 16, 2025 20:30 UTC
Laughlin Whitney MChief Legal Officer
Tax withholdingCommon Stock 121 $21.58 $2,611.18
Disclosure

SEC source: 0001142750-25-000037 · wk-form4_1750105818.xml · nonDerivative · entry 2

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,367

F2 · kind: Shares withheld for tax purposes.

Read SEC document
June 15, 2025 Filed Jun 16, 2025 20:30 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionCommon Stock 496 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000037 · wk-form4_1750105818.xml · nonDerivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,488

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares acquired on the vesting of Restricted Stock Units.

Read SEC document
May 02, 2025 Filed May 6, 2025 16:47 UTC GrantRestricted Stock Units · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000030 · wk-form4_1746550048.xml · derivative · entry 1

Jones Daphne E · CIK 0001475924 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
May 02, 2025 Filed May 6, 2025 16:47 UTC GrantRestricted Stock Units · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000027 · wk-form4_1746550015.xml · derivative · entry 1

Huber Celia P · CIK 0002066163 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
May 02, 2025 Filed May 6, 2025 16:47 UTC GrantRestricted Stock Units · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000029 · wk-form4_1746550037.xml · derivative · entry 1

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
May 02, 2025 Filed May 6, 2025 16:47 UTC GrantRestricted Stock Units · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000028 · wk-form4_1746550025.xml · derivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
May 02, 2025 Filed May 6, 2025 16:46 UTC GrantRestricted Stock Units · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000026 · wk-form4_1746550004.xml · derivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
May 02, 2025 Filed May 6, 2025 16:46 UTC GrantRestricted Stock Units · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000025 · wk-form4_1746549993.xml · derivative · entry 1

Hinton James H. · CIK 0001905630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
May 02, 2025 Filed May 6, 2025 16:44 UTC GrantRestricted Stock Units · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000023 · wk-form4_1746549877.xml · derivative · entry 1

Caballero Jorge A. · CIK 0001899928 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
May 02, 2025 Filed May 6, 2025 16:46 UTC GrantRestricted Stock Units · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000024 · wk-form4_1746549982.xml · derivative · entry 1

Fontenot Teri G. · CIK 0001661066 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
April 19, 2025 Filed Apr 21, 2025 22:09 UTC Exercise / conversionRestricted Stock Units · Derivative 3,019 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000019 · wk-form4_1745273386.xml · derivative · entry 2

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,019 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. Accordingly, the number of RSUs identified in this row vested on April 19, 2025.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
April 19, 2025 Filed Apr 21, 2025 22:09 UTC Exercise / conversionCommon Stock 3,019 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000019 · wk-form4_1745273386.xml · nonDerivative · entry 1

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,472

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN common stock acquired on the vesting of Restricted Stock Units ("RSUs").

Read SEC document
April 19, 2025 Filed Apr 21, 2025 22:08 UTC Exercise / conversionRestricted Stock Units · Derivative 3,019 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000018 · wk-form4_1745273333.xml · derivative · entry 2

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,019 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. Accordingly, the number of RSUs identified in this row vested on April 19, 2025.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
April 19, 2025 Filed Apr 21, 2025 22:08 UTC Exercise / conversionCommon Stock 3,019 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000018 · wk-form4_1745273333.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,937

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

Read SEC document
April 19, 2025 Filed Apr 21, 2025 22:07 UTC Exercise / conversionRestricted Stock Units · Derivative 3,019 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000017 · wk-form4_1745273243.xml · derivative · entry 2

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,019 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. Accordingly, the number of RSUs identified in this row vested on April 19, 2025.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
April 19, 2025 Filed Apr 21, 2025 22:07 UTC Exercise / conversionCommon Stock 3,019 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000017 · wk-form4_1745273243.xml · nonDerivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,273

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

Read SEC document
April 19, 2025 Filed Apr 21, 2025 22:06 UTC Exercise / conversionRestricted Stock Units · Derivative 3,019 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000016 · wk-form4_1745273169.xml · derivative · entry 2

Caballero Jorge A. · CIK 0001899928 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,019 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. Accordingly, the number of RSUs identified in this row vested on April 19, 2025.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
April 19, 2025 Filed Apr 21, 2025 22:06 UTC Exercise / conversionCommon Stock 3,019 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000016 · wk-form4_1745273169.xml · nonDerivative · entry 1

Caballero Jorge A. · CIK 0001899928 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

Read SEC document
February 21, 2025 Filed Feb 25, 2025 01:53 UTC
Laughlin Whitney MChief Legal Officer
Tax withholdingCommon Stock 79 $25.84 $2,041.36
Disclosure

SEC source: 0001142750-25-000013 · wk-form4_1740448389.xml · nonDerivative · entry 2

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,992

F2 · kind: Number of shares withheld for tax purposes.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 01:53 UTC
Laughlin Whitney MChief Legal Officer
GrantCommon Stock 264 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000013 · wk-form4_1740448389.xml · nonDerivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,071

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 15, 2022. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, annual year-over-year performance targets based, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") over a three-year period beginning on January 1, 2022 and ended December 31, 2024. As a result, 66% of the target amount of PRSUs for this award were deemed earned and vested.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 01:52 UTC
Hagan Mark ChristopherChief Information and Digital
Tax withholdingCommon Stock 954 $25.84 $24,651.36
Disclosure

SEC source: 0001142750-25-000012 · wk-form4_1740448316.xml · nonDerivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,708

F2 · kind: Number of shares withheld for tax purposes.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 01:52 UTC
Hagan Mark ChristopherChief Information and Digital
GrantCommon Stock 2,664 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000012 · wk-form4_1740448316.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,662

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 15, 2022. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, annual year-over-year performance targets based, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") over a three-year period beginning on January 1, 2022 and ended December 31, 2024. As a result, 66% of the target amount of PRSUs for this award were deemed earned and vested.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:38 UTC
Grace CarolineDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 77,048 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · derivative · entry 8

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,048

Underlying: Common Stock · 77,048 shares

Expires not disclosed

F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F8 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:38 UTC
Grace CarolineDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 76,569 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · derivative · entry 7

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,569

Underlying: Common Stock · 76,569 shares

Expires not disclosed

F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F7 · derivative.exercise_date: The Performance Restricted Stock Units ("PRSU") identified in this row were granted on January 15, 2024 and will be eligible for vesting based upon the achievement of a performance requirement. The ultimate number of PRSUs that can be deemed earned and vested under this award depends on the absolute total shareholder return for the period beginning on January 15, 2025 and ending on December 31, 2027.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:38 UTC
Grace CarolineDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 10,663 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · derivative · entry 6

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,652

Underlying: Common Stock · 10,663 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:38 UTC
Grace CarolineDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 4,893 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · derivative · entry 5

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,042

Underlying: Common Stock · 4,893 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:38 UTC
Grace CarolineDirector · Chief Executive Officer
Tax withholdingCommon Stock 2,512 $26.12 $65,613.44
Disclosure

SEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · nonDerivative · entry 4

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,345

F2 · kind: Shares withheld for tax purposes.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:38 UTC
Grace CarolineDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,663 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · nonDerivative · entry 3

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,857

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares acquired on the vesting of Restricted Stock Units.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:38 UTC
Grace CarolineDirector · Chief Executive Officer
Tax withholdingCommon Stock 1,451 $26.12 $37,900.12
Disclosure

SEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · nonDerivative · entry 2

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,194

F2 · kind: Shares withheld for tax purposes.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:38 UTC
Grace CarolineDirector · Chief Executive Officer
Exercise / conversionCommon Stock 4,893 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000004 · wk-form4_1737142724.xml · nonDerivative · entry 1

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,645

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares acquired on the vesting of Restricted Stock Units.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:37 UTC
Laughlin Whitney MChief Legal Officer
GrantRestricted Stock Units · Derivative 10,719 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · derivative · entry 10

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,719

Underlying: Common Stock · 10,719 shares

Expires not disclosed

F8 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F9 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:37 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 749 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · derivative · entry 9

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,521

Underlying: Common Stock · 749 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F7 · derivative.exercise_date: . The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:37 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 196 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · derivative · entry 8

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202

Underlying: Common Stock · 196 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:37 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 138 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · derivative · entry 7

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 138 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:37 UTC
Laughlin Whitney MChief Legal Officer
Tax withholdingCommon Stock 223 $26.12 $5,824.76
Disclosure

SEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · nonDerivative · entry 6

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,807

F2 · kind: Number of shares withheld for tax purposes.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:37 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionCommon Stock 749 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · nonDerivative · entry 5

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,030

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares acquired on the vesting of Restricted Stock Units.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:37 UTC
Laughlin Whitney MChief Legal Officer
Tax withholdingCommon Stock 59 $26.12 $1,541.08
Disclosure

SEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · nonDerivative · entry 4

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,281

F2 · kind: Number of shares withheld for tax purposes.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.